NuGenerex Immuno-Oncology Inc – Filings and Transcripts – BamSEC

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late annual filing notification for FY 2021

ended 04/30/21 Q3

ended 01/31/21 Q2

ended 10/31/20 Q1 2021 – amended

ended 10/31/20 Q1

Prospectuses and Registrations Filter

Commission order revoking registration

Initial registration of new securities – amended

Initial registration of new securities – amended

Initial registration of new securities

Initial registration of new securities

Ownership

No filings in this category.

News Filter

Change of Control, Shareholder Vote Results, Other Events

Generex Biotechnology Corporation

Proxies Filter

Preliminary info

Other Filter

SEC STAFF ACTION

SEC STAFF ACTION

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC